Zobrazeno 1 - 10
of 34
pro vyhledávání: '"M. Marrollo"'
Autor:
R. Tersigni, C. Papi, A. Kohn, R. Monterubbianesi, M. Marrollo, R. Cosintino, L. Alessandroni
Publikováno v:
Techniques in Coloproctology. 15:407-412
Perianal fistulas are frequent complications of Crohn’s disease. Intravenous infliximab can control perianal disease and promote perianal fistula closure. Perifistular infliximab injections have been proposed for patients who are intolerant or unre
Autor:
Renata D'Incà, Fabiana Castiglione, S Segato, Gabriele Riegler, A Corbellini, Paolo Gionchetti, Dana Duricova, Sanromán Al, M R Panelli, D. Valpiani, Sandro Ardizzone, Pia Munkholm, Aurora Bortoli, I. Arena, M Marrollo, Niels C Pedersen, Javier P. Gisbert
Publikováno v:
Alimentary Pharmacology & Therapeutics. 34:724-734
Aliment Pharmacol Ther 2011; 34: 724–734 Summary Background Inflammatory bowel disease (IBD) frequently affects women during their reproductive years. Pregnancy outcome in women with IBD is well described, particularly in retrospective studies. Aim
Autor:
Angelo Viscido, M. Marrollo, Cosimo Prantera, Vito Annese, Marco Daperno, Alessandro Armuzzi, Gabriele Riegler, R. Sostegni, Anna Kohn, Antonio Gasbarrini, Gianmichele Meucci, Ambrogio Orlando, Livia Biancone, S. Peralta, Maria Cappello
Publikováno v:
Alimentary Pharmacology & Therapeutics. 26:747-756
Background Severe ulcerative colitis is a life-threatening disorder, despite i.v. glucocorticoids treatment. Infliximab has been proposed as a safe rescue therapy. Aim To evaluate short- and long-term effectiveness and safety of infliximab in severe
Autor:
Broglia L, Angelo Viscido, Francesca Maccioni, Plinio Rossi, R. Masciangelo, R. Caprilli, M. Marrollo
Publikováno v:
Abdominal Imaging. 25:219-228
The purpose of this study was to assess the accuracy of magnetic resonance imaging (MRI) in evaluating Crohn disease (CD) activity. The intestinal inflammatory activity is usually present in patients under pharmacologic treatment, despite their clini
Autor:
M. Marrollo, Marina Davoli, Anna Kohn, R. Monterubbianesi, Elisa Stasi, Carlo A. Perucci, Valeria Fano, Cosimo Prantera
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 44(5)
Background Today we are observing an increasing incidence of ulcerative colitis associated with an improved survival of patients. Aim To analyse current rates, outcomes, and costs of inpatient care for ulcerative colitis patients of central Italy. Me
Autor:
A, Kohn, M, Daperno, A, Armuzzi, M, Cappello, L, Biancone, A, Orlando, A, Viscido, V, Annese, G, Riegler, G, Meucci, M, Marrollo, R, Sostegni, A, Gasbarrini, S, Peralta, C, Prantera
Severe ulcerative colitis is a life-threatening disorder, despite i.v. glucocorticoids treatment. Infliximab has been proposed as a safe rescue therapy.To evaluate short- and long-term effectiveness and safety of infliximab in severe refractory ulcer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::344f65dc4233d05bec414f0cf4652ffc
http://hdl.handle.net/11697/463
http://hdl.handle.net/11697/463
Publikováno v:
Digestive and Liver Disease. 43:S221-S222
Autor:
Renzo Caprilli, D. Melideo, P. Stornelli, R. Iannarelli, Giovanni Latella, E. Storelli, M. Marrollo, Marco Valenti
Publikováno v:
Scopus-Elsevier
Background. Whilst upper gastrointestinal disturbances are frequently observed in patients with diabetes mellitus, little is known about the prevalence of Helicobacter pylori infection and peptic disease in these patients. Aim. To evaluate prevalence
Autor:
Anna Kohn, Claudio Papi, M. Marrollo, R. Tersigni, L. Alessandroni, R. Monterubbianesi, R. Cosintino
Publikováno v:
Digestive and Liver Disease. 43:S184